Cannabis Law Report

JUNE 8, 2022

MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial. He previously served as the global CEO for both Sandoz and Alcon, at Novartis Group, where he served on the Executive Committee from 2008 to 2016.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

Veriheal

OCTOBER 20, 2021

Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. He is said to have microdosed with LSD for the last 25 years of his life, passing away on April 29, 2008.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

Otherside Farms

JULY 4, 2022

With THC and CBD, CBC Isolate is the most effective depression treatment. In 2008, Italian and British scientists found that CBC Isolate and other cannabinoids are as effective against MRSA as antibiotics like Vancomycin. Stress is a significant cause of depression. Antibacterial. The 1980s saw some of the best CBC Isolate research.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

Cannabis Law Report

JULY 24, 2022

The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. It was not until the 1990s that psychedelics research was resumed, first with psilocybin and DMT, and since 2008 also with LSD. percent annually to $9.8

Research and Development 52

Research and Development Legalization Treatment Patients 52

CannaMD

JULY 28, 2020

To stay up-to-date with the latest studies and legal regulations surrounding medical marijuana treatment, be sure to follow CannaMD on Facebook and sign up for our newsletter, below! But when marijuana is legal, this dynamic is changed. Find Out if You Qualify. You may be eligible for medical marijuana! Get Started. Join 46K+ Subscribers!

Legalization 52

Legalization Recreational Environment Cannabis 52

Healer

APRIL 9, 2019

Cannabinoids can modulate bone remodeling, often promoting bone growth and inhibiting bone resorption, and some are currently being studied for prevention and treatment of osteoporosis. 2008): 169-182. The investigation used a bioinformatics approach, obtaining microarray data via the GEO database (www.ncbi.nlm.nih.gov/geo/).

Research and Development 52

Research and Development Cannabinoids Data CBD 52

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Entrepreneurs and businesses leverage this data to navigate the competitive landscape, ensuring they meet market demands.

Marijuana 52

Marijuana Dispensary Research and Development Supply Chain 52

Project CBD

FEBRUARY 27, 2023

In the absence of an answer — or a cure — treatment is the name of the game for fibromyalgia. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” That seemed to make all the difference. © Copyright, Project CBD.

THC 144

THC CBD Sleep Clinical Trials 144

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). million) than in 2008 (6.1

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ). It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). The latter remains a dangerous drug and is considered higher risk for treatment than CBD (TGA 2019 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

MARCH 31, 2021

The CDC report found “a precipitous national decline in adolescent treatment admissions, particularly in states legalizing recreational marijuana use,” states study author Jeremy Mennis, Ph.D. “7 CDC data aligns with most surveys. CDC data aligns with most surveys. The data on this issue is clear, consistent, and available.

Treatment 52

Treatment Data Vaping Recreational 52

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Data 52

Data Safety Cannabinoids Cannabis 52

SpeedWeed

JULY 30, 2021

Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . Furthermore, the measurement of available data elements can be affected by [the] very context of marijuana legalization. in 2015 to 6.7% in 2019,” the Colorado report stated.

Dispensary 52

Dispensary Data Safety Cannabinoids 52

The Cannigma

DECEMBER 8, 2021

It’s not with volumes of data, and facts and figures. JMP: It started in 2008. EG: So, at that time, through your treatment, were you using cannabis? It’s all about understanding where your state legislature is at. What are they emotionally comfortable with? Because this is how we advance public policy. JMP: Always.

Access 81

Access Policy Patients Cannabis 81

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. An advocate for the appropriate use of consciousness-expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication. in/julie-holland-b1a7a13/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. Regarding the warning for specific populations that based on animal data the pharmaceutical may cause fetal harm.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JANUARY 21, 2019

All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. . The California treatment of pension income is generally the same as federal treatment. Taxable Year 2008 – California Conformity to Federal Law. Economic Stimulus Act of 2008 (PL 110-185, H.R.

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40